Last updated on April 2018

Neoadjuvant Nab-PTX and Trastuzumab for ER Negative and HER2 Positive Breast Cancer

Brief description of study

The purpose of this study is to evaluate the efficacy and safety of nab-PTX and trastuzumab for ER negative and HER2 positive operable (tumor size of 3cm or less and N0) breast cancer.

Clinical Study Identifier: NCT02598310

Find a site near you

Start Over

Osaka Medical College

Takatsuki, Japan
  Connect »